Disseminated Tuberculosis with Rare Manifestations in a Young Immunocompetent Male Patient

Text
A rare case of disseminated tuberculosis (TB) with cutaneous, cerebrovascular, and thromboembolic manifestations was reported in a 24-year-old immunocompetent male patient, according to a case study published in Cureus. The report highlights the atypical presentation of TB, which typically affects immunocompromised individuals, and underscores the challenges of diagnosing such cases in patients without known risk factors.

The patient presented with fever, weight loss, and multiple skin lesions, which initially led to a misdiagnosis of a dermatological condition. Further investigation revealed cerebrovascular complications, including a stroke, and thromboembolic events, such as deep vein thrombosis. Diagnostic tests, including imaging and microbiological analysis, confirmed the presence of Mycobacterium tuberculosis in multiple organ systems. The case report, published on June 27, 2026, emphasizes the importance of considering TB in differential diagnoses for patients with unusual symptoms, even in the absence of typical risk factors.

According to the study, disseminated TB—also known as miliary TB—occurs when the infection spreads beyond the lungs to other parts of the body. While it is more common in individuals with weakened immune systems, such as those with HIV or undergoing immunosuppressive therapy, this case demonstrates that immunocompetent individuals are not entirely protected. The authors note that the patient’s lack of known immunodeficiency complicates the clinical picture, requiring a broader diagnostic approach.

The case report details the patient’s treatment course, which included a standard anti-TB regimen of isoniazid, rifampin, ethambutol, and pyrazinamide. Additionally, anticoagulation therapy was administered to manage the thromboembolic events. The patient showed improvement over several weeks, though the study acknowledges the risk of long-term complications, including neurological deficits from the cerebrovascular incident.

Medical experts caution that TB remains a significant global health challenge, with the World Health Organization (WHO) reporting 10 million cases worldwide in 2022. While the majority of TB cases are pulmonary, extrapulmonary manifestations—such as those described in this case—account for 15–20% of infections. The study’s authors stress that early diagnosis is critical, as delayed treatment can lead to severe complications.

The case also raises questions about the mechanisms by which TB might disseminate in immunocompetent individuals. The study suggests that factors such as genetic predisposition, environmental exposure, or undiagnosed immune suboptimal function could play a role. However, the authors note that further research is needed to fully understand these pathways.

Public health officials emphasize that TB prevention and early detection remain vital, particularly in high-burden regions. The WHO recommends regular screening for individuals at risk, including those with close contact with TB patients or living in crowded conditions. In this case, the patient’s initial symptoms were non-specific, highlighting the need for clinicians to maintain a high index of suspicion, especially in areas with moderate TB prevalence.

The study’s findings align with broader trends in TB research, which increasingly focus on atypical presentations and the role of host immunity in disease progression. A 2023 review in the Lancet Infectious Diseases noted that extrapulmonary TB is often underdiagnosed, particularly in regions with limited access to advanced diagnostic tools. The case described in Cureus underscores the importance of integrating molecular diagnostics, such as nucleic acid amplification tests, into routine TB screening protocols.

While the patient’s outcome was favorable, the case serves as a reminder of TB’s potential to manifest in unexpected ways. The authors conclude that clinicians should remain vigilant, particularly when evaluating patients with unexplained systemic symptoms, and consider TB even in immunocompetent individuals.

Quoted text
“The atypical presentation of TB in this patient highlights the need for a comprehensive diagnostic approach,” the study states. “Clinicians must recognize that TB can affect multiple systems and may not always present with the classic symptoms.”

Source
Cureus, “Disseminated Tuberculosis With Cutaneous, Cerebrovascular, and Thromboembolic Manifestations in a Young Immunocompetent Male Patient: A Case Report,” June 27, 2026.

Text
The case also underscores the importance of multidisciplinary care in managing complex TB cases. The patient’s treatment involved collaboration between infectious disease specialists, neurologists, and hematologists to address the diverse manifestations of the disease. This approach reflects current guidelines from the Centers for Disease Control and Prevention (CDC), which recommend tailored treatment plans for extrapulmonary TB.

Public health officials note that TB remains a leading cause of death from a single infectious agent, surpassing HIV/AIDS. In 2022, the WHO estimated that 1.6 million people died from TB, with many cases going undiagnosed or untreated. The study’s authors argue that improving access to diagnostics and treatment, particularly in low-resource settings, is essential to reducing the global burden of the disease.

For patients with TB, adherence to the full course of treatment is critical to preventing drug-resistant strains. The case report emphasizes that incomplete treatment can lead to relapse and the development of multidrug-resistant TB, which is significantly harder to manage.

As research continues to explore new diagnostic tools and therapies, the case described in Cureus adds to the growing body of evidence on TB’s diverse clinical presentations. The study’s authors hope that their findings will contribute to more accurate diagnoses and improved outcomes for patients with atypical TB manifestations.

Text
In summary, the case of disseminated TB in a young immunocompetent male highlights the evolving understanding of TB’s clinical spectrum. While the disease is traditionally associated with immunocompromised individuals, this report demonstrates that it can affect anyone, necessitating a broad diagnostic approach. The findings reinforce the importance of early detection, multidisciplinary care, and continued research into TB’s mechanisms and management.